Synerzys Lifecare Pvt Ltd

15/12/2013

Delivered a talk at Pharmatech 2013 on 12th Dec at Ahmedabad. Proud to have shared Dais with Prof Ambikanandan Mishra.

http://synerzys.com/blog/pharma-business-dynamics-in-row-markets-challenges-opportunities-for-indian-pharma-sme-manufacturers/

?NATIONAL CONFERENCE ON PHARMA & ALLIED INDUSTRY : PHARMA TECH 2013? with the theme, ?India ?

30/07/2013

Whole cell >> Acellular >> MAPS . Multiple Antigen Presentation System is the new method for vaccine design.
www.synerzys.com

http://www.sciencedaily.com/releases/2013/07/130729161803.htm

Researchers have developed a new method of vaccine design -- Multiple Antigen Presentation System. It could speed new vaccine development for range of globally serious pathogens, infectious agents. Method permits rapid construction of new vaccines that bring together benefits of whole-cell and acell...

02/05/2013

http://www.prnewswire.com/news-releases/vatsala-naageshwaran-of-absorption-systems-to-present-at-disso-2013-international-conference-in-mumbai-india-on-may-3rd-205412291.html

Vatsala Naageshwaran of Absorption Systems to Present at Disso 2013 International Conference in Mumbai, India on May 3rd.

27/04/2013

Indian Vaccine Manufacturer saves USD 150 mio for GAVI, by offering 'lowest ever' price for pentavalent vaccine
www.synerzys.com

http://www.dnaindia.com/money/1826680/report-gavi-bio-e-tie-up-shrinks-vaccine-price

Vaccine firm Biological E has stepped into the Big Pharma territory with its agreement with the Gavi Alliance for supply of 'pentavalent vaccine'. - Money dna

24/04/2013

Sid Bhoopathy, COO of Absorption Systems, Selected as a Philadelphia Business Journal "40 Under 40" Award Winner.
www.synerzys.com

http://www.prnewswire.com/news-releases-test/sid-bhoopathy-coo-of-absorption-systems-selected-as-a-philadelphia-business-journal-40-under-40-award-winner-203644721.html

23/04/2013

http://timesofindia.indiatimes.com/business/india-business/Pharma-companies-fortunes-tied-to-GDP/articleshow/19671339.cms

There seems to be a strong co-relation between the domestic pharma market and growth trends in the country's GDP.

09/04/2013

http://www.mediawebsite.net/ausas/story/?catSetID=&catID=&nrid=202034891&page=1

Absorption Systems Partners with Synerzys to Promote Biopharmaceutics Classification System (BCS) Testing of Drugs. American Testing Lab and Indian Consulting Firm Work to Broaden Acceptance of the BCS.

02/04/2013

Indian Generic Manufacturers win legal battle against Novartis to continue selling generic version of Glivec (Imatinib)
www.synerzys.com

http://articles.economictimes.indiatimes.com/2013-04-01/news/38189607_1_glivec-patent-protection-indian-patent-office

NEW DELHI: The Supreme Court today rejected swiss drug major Novartis' challenge to Section 3(d) of the Indian Patents act which stood in way of the company obtaining a patent over its anti cancer...

28/03/2013

Absorption Systems under GDUFA , self identifies as BCS, BE & BA testing facility and is now on list of FDA's list of registered facilities
www.synerzys.com

http://www.prnewswire.com/news-releases/absorption-systems-registers-with-fda-as-a-generic-drug-facility-under-gdufa-199945231.html

Absorption Systems Registers with FDA as a Generic Drug Facility under GDUFA. Self-identifies as a Biopharmaceutics Classification System (BCS), Bioequivalence, and Bioavailability Testing Facility.

25/03/2013

Indian API manufacturers geared up to meet EU challenge of new API regulations coming into effect from July 2013.
www.synerzys.com

http://www.fiercepharmamanufacturing.com/story/india-has-plan-meet-europes-new-api-regs/2013-03-21

All the excitement prompted by a new import law that has European drugmakers and their API suppliers worried about a regulatory train wreck come July appears to have moved the needle in one crucial API producing country: India. An official there says India now has a plan in place to get the required...

19/03/2013

News SARO chhe (News is good - in gujarati)
www.synerzys.com

http://timesofindia.indiatimes.com/home/science/Diabetic-capital-Gujarat-makes-own-molecule/articleshow/19053651.cms

Pharma major Cadila Healthcare may soon become one of a handful of Indian companies to launch an indigenous molecule.

25/02/2013

India : Pharmacy of the World!
www.synerzys.com

http://www.pharmabiz.com/PrintArticle.aspx?aid=73910&sid=1

Every fifth tablet, capsule and injectable in generic drugs consumed anywhere in the world is manufactured in India, if the latest data is an indication.This was disclosed by Union Health Minister Ghulam Nabi Azad in the Lok Sabha on Friday, ascertaining the dominance of India as the pharmacy of the...